Logo of jester cap with thought bubble.

Image source: The Motley Fool.

Greenlight Capital RE Ltd (NASDAQ:GLRE)
Q2 2020 Earnings Call
Aug 6, 2020, 9:00 a.m. ET

Contents:

  • Prepared Remarks
  • Questions and Answers
  • Call Participants

Prepared Remarks:

Operator

Good day, and thank you for joining the Greenlight Re Conference Call for the Second Quarter of 2020 Earnings.

The company reminds you that forward-looking statements that may have been made in this call are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact, but rather reflect the company's current expectations, estimates and predictions about future results and events that are subject to risks, uncertainties and assumptions, including those enumerated by the company's Form 10-K/A for the year ended December 31, 2019, and other documents filed by the company with the SEC.

If one or more risks or uncertainties materialize or if the company's underlying assumptions prove to be incorrect, actual results may vary materially from what the company projects. The company undertakes no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise except required by law. After the prepared remarks, we will be conducting a question-and-answer session. [Operator Instructions]

I would now like to turn the conference over to Greenlight Re's CEO Mr. Simon Burton. Please go ahead, sir.

Simon Burton -- Chief Executive Officer

Good morning and thank you for joining our call today. I'm pleased to report that we made solid progress in several fronts during the quarter. Our underwriting results, excluding the impact of COVID-19, which I'll discuss shortly generated a combined ratio of 95.7%. This result continues the trend of improved underlying performance and reflects the repositioning of our underwriting business over the past three years.

During this time, we have expanded the lines of business we write and increased our participation in excess of loss contracts when the economic support it, thereby replacing some of our lower performing quota share contracts with higher-margin business. It is notable that over the past three years, we have decided to not renew approximately two-thirds of the premium that was enforced as of July 2017. So we have been acutely selective of the business that we keep.

Looking forward, the improvement in market conditions that started last year is now accelerating. Over the past few months, we have seen risk placements in specialty classes with significantly improved terms. We have also seen that attempts to place risks with only modest pricing improvements are often met with shortfalls in capacity, a clear sign of a healthy market. Given the recent timing of these more significant pricing movements, the impact on our income statement this quarter is negligible, although we are optimistic that we will see the benefit over the next year.

Our exposure to the pandemic continues to be manageable and small in comparison to the industry as a whole, a result that reflects several factors. We have minimal exposure to some of the highly exposed lines of business, where coverage is uncontested, such as event cancellation, travel insurance, trade credit, directors and officers liability and long-term life. While the mortgage market has seen an increase in delinquencies, the financial impact on our portfolio has been offset by reductions in profit commissions we paid to our cedents.

Additionally over the last two years, we cut back on the amount of mortgage business we write, which reduces our exposure to the newer and therefore, riskier underlying mortgage contracts. And as we anticipated, our auto business has shown a reduction in claim frequency through the lockdown period in the US.

Our second quarter COVID-19 net loss estimates of $6 million contributed 5.5 points to our total combined ratio of 101.2%. This loss estimate relates primarily to our Lloyd's multi-class contracts and certain property catastrophe contracts with identifiable business interruption exposure. Regarding our key financial metric, we grew book value per share by 1.5% as we took advantage of the opportunity to repurchase shares at a significant discount to book.

On the investment side David will discuss Solasglas and the broader environment in a moment, but it's notable that contributing to our overall investment result this quarter is a gain of $3.3 million in the valuation of certain strategic investments made by our innovations unit. The pandemic has exposed both winners and losers among our innovation partners. And overall, I'm pleased with our progress and excited about the divisions potential.

Finally, AM Best recently concluded its annual review with the decision to affirm our A minus rating. Ratings pressure has been a common theme in the industry in recent months with several notable ratings downgrades. We are pleased with AM Best decision and I look forward to executing our plans to build shareholder value as we move into a much improved market conditions.

Now I'd like to turn the call over to David.

David Einhorn -- Chairman of the Board of Directors

Thanks, Simon, and good morning everyone. The Solasglas fund returned 0.3% in the second quarter. Longs contributed 7.6%, while the shorts detracted 7.3% and macro was essentially flat. During the quarter the S&P 500 Index returned 20.5%. Long positions in Green Brick Partners. The Chemours Company and Brighthouse Financial were the biggest winners. Green Brick partners returned 47% as the company reported record breaking Q1 results and margin growth despite COVID related disruptions.

Over the past couple of years Green Brick strategically diversified both its geographic footprint and product line, including growing its entry-level segment. Management expects the improved affordability of its product line to allow the company to maintain or even grow its market share in the current economic climate. Green Brick reported very strong second quarter earnings on Tuesday, and the stock appreciated putting August off to a good start.

Shares of Chemours climbed 73% in the second quarter as the broader market rallied and fierce over the company's liquidity position abated. On its first quarter earnings call management announced significant cost cuts and capex reductions in anticipation of several challenging quarters ahead. Additionally, resilient demand and some of Chemours US end markets, including do-it-yourself paint and single-family home building have helped offset weaknesses in other markets; such as automotive paint.

Brighthouse financial returned 15% in the second quarter, yet remained down 29% on the year as of June 30. In May, the company announced first quarter GAAP earnings per share of $47 much more than the entire price of the company's shares due to its market hedges. Brighthouse accelerated its share repurchases buying back a total 12% of the stock during the first four months of the year. Management reiterated its target, repurchasing $1.5 billion total by the end of 2021 implying that the company intends to purchase roughly an additional quarter of the current shares outstanding over the next 18 months.

Book value at the end of the first quarter was $172 per share, yet the stock trades at only 16% of that amount and just 3.3 times adjusted earnings. Our Tesla short detracted from performances as the stock more than doubled in the quarter. The company surprised the market by reporting a first quarter profit in April, despite a weeks long shutdown of its production facilities, due to the pandemic. The profit was largely driven by a sharp increase in regulatory credit sales, the accounting for which we doubt conforms to GAAP, as it doesn't match the expense recognized by its customer. Tesla's cash collections were relate to car sales that generate the credits. Absent these regulatory credit sales Tesla would have reported a loss.

Solasglas returned 1.3% in July, bringing 2020 year-to-date results for Solasglas to negative 6.6%. Net exposure was approximately 18% long in the investment portfolio at the end of the second quarter and roughly 16% at the end of July. While the COVID-19 pandemic has brought much uncertainty to the financial markets, we're excited about the hardening reinsurance market coupled with the opportunities in our investment portfolio. We plan to increase the investment portfolio throughout the rest of the year from roughly one-third of Greenlight Re's surplus to 50% of surplus are diversifying the composition further.As Tim will discuss, we made substantial share repurchases during the quarter, because we believe that a 55% of book value as our markets are improving this is the best investment we can make.

Now I'd like to turn the call over to Tim to discuss the financial results.

Tim Courtis -- Chief Financial Officer

Thanks, David. For the second quarter of 2020 Greenlight Re reported a small net loss of $63,000, compared to net income of $15.3 million for the comparable period in 2019. For the six months ended June 30, 2020, we reported a net loss of $40.3 million, compared to net income of $21.2 million for the first six months of 2019. The net loss per share was $1.12, compared to net income of $0.58 per fully diluted share for the same period in 2019.

Net premiums earned were $219.4 million for the first six months of 2020, a decrease of 11% from the prior year period. Both growth and ceded premiums written decreased from the prior year, primarily due to the non-renewal of certain auto business, partially offsetting the gross premium decrease was new business being written in several specialty lines, including crop, energy and cyber business.

The company reported a small underwriting loss of $1.3 million during the quarter and a combined ratio of 101.2%. As Simon mentioned the quarter's results included COVID-19 net loss estimates of $6 million, which added 5.5 percentage points to the combined ratio. The combined ratio for the year-to-date was 100%, which includes 2.7 percentage points of estimated losses from COVID-19.

For general and administrative expenses incurred during the first half of 2020 were $12.9 million, which is a decrease of $1.8 million or approximately 12% over the prior year period, this decrease was primarily due to lower personnel costs and to a lesser extent, lower travel, office and related costs incurred during the second quarter from shelter in place orders. We reported total net investment income of $5.5 million during the second quarter of 2020, which includes net investment income of $1.6 million on our investment in Solasglas, reflecting a net gain of 30 basis points on the Solasglas fund.

Other net investment income contributed $3.9 million during the quarter, a significant reduction in investment income on collateral assets resulting from interest rate reductions in March was more than offset by valuation gains on certain innovation investments during the quarter.

During the second quarter, the company repurchased approximately 1.16 million shares at an average cost of $6.69 per share on average, a discount of approximately 43% from the company's March 31, fully diluted book value. The fully diluted book value per share as of June 30, 2020 was $11.81, a 1.5% increase from $11.63 per share reported at March 31, 2020 and a decrease of 13% from $13.58 per share reported at June 30th 2019.

Our Annual Shareholders Meeting, which usually takes place in the second quarter of the year will now take place on October 29, 2020. The meeting was moved due the logistics of shelter-in-place orders in the Cayman Islands.

Now, I'll turn the call back to the operator and open it up for questions.

Questions and Answers:

Operator

Thank you. We will now begin the question-and-answer session. [Operator Instructions] And the first question will come from Mikel Abasolo with Solo Capital Management. Please go ahead.

Mikel Abasolo -- Solo Capital Management -- Analyst

Thank you for taking my question. This is short and very concise one. I believe that you are far from completing the buyback as authorization, but I would like you to give first, some color on what is your intention if the discount remains where it is today. Will you be completing the authorization soon? Will you renew it to keep on buying? Thank you.

Simon Burton -- Chief Executive Officer

Mikel, thanks for the question. This is, Simon. So...

Mikel Abasolo -- Solo Capital Management -- Analyst

Hi.

Simon Burton -- Chief Executive Officer

As David said, the opportunity to buyback our shares at the current discount is tremendous. Of course, we'd like to see the discount reverse ultimately, it is a balance between competing interests of using the capital to support our business where, as you've heard, there are tremendous amount of opportunities and the market opportunities are only improving. But for now the buyback is continuing and will evaluate that as it goes.

Mikel Abasolo -- Solo Capital Management -- Analyst

Okay, thank you.

Operator

[Operator Instructions] At this time, it appears there are no questions in the question queue.

[Operator Closing Remarks]

Duration: 15 minutes

Call participants:

Simon Burton -- Chief Executive Officer

David Einhorn -- Chairman of the Board of Directors

Tim Courtis -- Chief Financial Officer

Mikel Abasolo -- Solo Capital Management -- Analyst

More GLRE analysis

All earnings call transcripts

AlphaStreet Logo